Case Report: Effective methotrexate removal by combined hemodialysis and polymeric resin hemoadsorption
BackgroundHigh-dose methotrexate (HDMTX) is central to treating primary central nervous system lymphoma but carries a risk of acute kidney injury (AKI), which can delay methotrexate (MTX) clearance and increase toxicity. Glucarpidase is the treatment of choice for MTX toxicity, but limited access in...
Saved in:
| Main Authors: | Maria Rita Dias, Carla Nicolau, Hugo Ferreira, Sérgio Chacim, Isabel Oliveira, Gonçalo de Câmara Negalha, José Mário Mariz, José Maximino Costa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Nephrology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneph.2025.1644079/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01) -
Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01) -
Risks of Oral Methotrexate Administration in Outpatients
by: Maria Ganeva, et al.
Published: (2014-11-01) -
Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial
by: Dhan Keshar Khadka, et al.
Published: (2016-01-01) -
Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial
by: Dhan Keshar Khadka, et al.
Published: (2016-01-01)